1. Introduction
It is well known that high-performance athletes are exposed to a multitude of training sessions and competitions that cause a lot of physical and mental stress, a fact that encourages many athletes to use ergogenic aids to cope with this stressful situation. Particularly volleyball is considered one of the most popular sports in the world [
1]. It involves specific tasks such as jumping, landing, blocking and throwing the ball, which in turn must be combined with fast movements, a fact that places high demands on the musculoskeletal system [
2].
Elsewhere, the use of caffeine it is considered as a potential ergogenic aid able to enhance the athletic performance of volleyball players [
3]. it is widely used as an ergogenic aid in both individual and team sports because of its rapid perceived stimulant effect in a wide range of sporting disciplines [
4]. In addition, it has been classified as a safe supplement by the International Society of Sports Nutrition (ISSN) [
5]. Its intake has been increased according with his positive effect on aerobic [
6,
7] and anaerobic activities [
3,
6,
8], increasing strength and power capacity [
9] by an enhance of intracellular calcium and Na
+-K
+ ATPase pump activity [
10], and delaying the onset of fatigue [
11] through activation on central nervous system blocks adenosine receptors [
11,
12,
13].
In this respect, caffeine has been well documented its effect in jump capacity [
3], nevertheless the effect on agility tests like change of direction is unclear, there is some evidence that conclude that caffeine did not improve it [
8], while other study in female volleyball players describe a significant positive effect [
14]. More evidence is needed to determine the effect of caffeine on agility, especially in women's volleyball. Gomez-Bruton et al (2021) concludes that acute caffeine intake is capable of enhance team sports performance in female athletes. Therefore, it could be effective as an ergogenic aid in female team athletes [
15].
Regarding to dose intake, its well stablished that a range from 3 to 9 mg/Kg enhance the athletic performance [
6,
8,
16,
17]. Concerning to the timing ingestion, because of his rapid absorption and plasma availability [
11], caffeine intake one hour before training session have been shown as an optimal strategy to enhance performance [
18]. Therefore, in the present study our team programmed a caffeine intake of 5mg/Kg of body mass one hour before the training session.
Volleyball has a pre-competitive phase and a long-competitive phase on its calendar, as with other team sports. The aim of the pre-competitive season is to prepare the athletes to maximize their adaptative response to competitions and to copy with psychophysiological demands of the competitive season. In this sense, appropriate load control must be managed in order to balance stress-recovery cycle and to maintain high performance during all season [
19,
20]. In recent decades, the term internal load in team sports is in the process of highlight the importance to control the fatigue and stress induced by competitions, training sessions and daily life, since it is a determinant, along with external load, of training outcome [
21,
22,
23]).
Accordingly, subjective wellness questionnaires are suggested as convenient instruments for measuring internal load in team sport athletes [
21,
24,
25]. The questionnaires reflect player's perception of muscle pain [
26], general fatigue [
25] sleep quality [
27], ratio of perceived exertion [
28] and psychological stress [
29].
Caffeine has been proven to deliver positive outcomes in reducing rating of perceived exertion [
30,
31,
32,
33], diminishes muscular soreness or damage [
34,
35] although to a lesser degree than males [
30,
33], and enhances performance in eumenorrhoeic female population [
4,
10,
36]. However, a main undesiderable aspect to consider of caffeine supplementation in athletes is that could affect negatively to quality sleep [
37], especially in female athletes due to the effect of caffeine remains longer in women than in men [
38]. Recent studies have highlighted the lack of research on caffeine dose-response including sleep, fatigue and performance assessments [
39,
40]. Indeed, recent studies reported that there are still more studies in males, with studies in females being scarce [
18], specifically on strength [
41]. Thus, studies on the effect of caffeine on strength in women are required.
Therefore, the purpose of this study is to establish the ergogenic effect of 5 g /Kg caffeine on wellness (sleep, fatigue, stress and muscle soreness) and physical performance (COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count) in female volleyball team athletes.
3. Results
Descriptive statistics were calculated for each internal intensity (Sleep, Stress, Fatigue and Muscle soreness) and external intensity variables (Handgrip dominant hand and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count) (see
Table 1).
Table 1 Within-week variations (MD-4, MD-3, and MD-1) of (i) internal intensity: Sleep, Stress, Fatigue and Muscle soreness, and (ii) external intensity: Handgrip dominant hand and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count (mean ± SD).
First, a repeated measures ANOVA with participants’ mean sleep did not reveal any significant main effect of supplementation condition, moment condition and interaction, F (1.7) = 2.85, p = 0.13, η2 = 0.28, F (2.14) = 2.88, p = 0.09, η2 = 0.29, and F<1, respectively. Second, a new repeated measures ANOVA with participants’ mean fatigue revealed a significant main effect of supplementation condition, F (1.7) = 7.29, p = 0.03, η2 = 0.51, with lower values in the supplementation condition (3.13± 1.69) than in the placebo condition (3.71± 1.71). However, the analysis did not reveal a significant effect of moment, F<1. The interaction between supplementation condition and moment condition, F (2.14) = 1.04, p = 0.37, η2 = 0.1, was not significant. Third, a new repeated measures ANOVA with participants’ mean stress did not showed a significant main effect of supplementation condition, F<1. Nevertheless, dataset revealed a significant effect of moment (2.14) = 4.69, p = 0.02, η2 = 0.40, with a decrement of values thought the week (3.81 to 2.88). The interaction between supplementation condition and moment condition, F (2.14) = 1.58, p = 0.23, η2 = 0.18, was not significant. Last, another repeated measures ANOVA with participants’ mean muscle soreness showed a significant main effect of supplementation condition, F (1.7) = 7.54, p = 0.02, η2 = 0.52, with lower values in the supplementation condition (3.08± 1.69) than in the placebo condition (3.88± 1.30). However, the analysis did not show a significant effect of moment, (2.14) = 2.46, p = 0.12, η2 = 0.26. The interaction between supplementation condition and moment condition, F<1, was not significant.
In the same direction, a news repeated-measures ANOVA with participants’ mean external intensity (handgrip dominant and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count) were performed to try to elucidate the main effects and interactions of different measures. Elsewhere, a repeated measures ANOVA with participants’ mean handgrip dominant did not reveal any significant main effect of supplementation condition, F (1.7) = 1.18, p = 0.32, η2 = 0.19, and moment condition, F<1. However, the dataset revealed an interaction supplementation x moment condition, F (2.14) = 9.56, p = 0.004, η2 = 0.65. Otherwise, another repeated measures ANOVA with participants’ mean handgrip non dominant did not revealed a significant main effect of supplementation condition, moment condition or interaction, F<1, in all cases. A repeated measures ANOVA with participants’ mean COD 505 test did not reveal any significant main effect of supplementation condition and interaction between supplementation condition and moment condition, F<1 in both cases. However, we found a main effect of moment, (2.14) = 4.61, p = 0.03, η2 = 0.39, with a decrement of values thought the week (4.31 to 4.14). Another repeated measures ANOVA with participants’ mean CMJ height revealed a significant main effect of supplementation condition, F (1.7) = 8.41, p = 0.02, η2 = 0.54, with higher values in the supplementation condition (35.61±5.47) than in the placebo condition (33.10±5.79). Notwithstanding, we found a main effect of moment, (2.14) = 6.40, p = 0.01, η2 = 0.47, with a decrement of values thought the week (32.44 to 34.68). The interaction between supplementation condition and moment condition, F<1, was not significant. Similar to above analysis, a repeated measures ANOVA with participants’ mean RJ height showed a significant main effect of supplementation condition, F (1.7) = 5.97, p = 0.04, η2 = 0.46, with higher values in the supplementation condition (29.61±2.86) than in the placebo condition (27.50±3.37). In addition, we found a main effect of moment, (2.14) = 8.57, p = 0.001, η2 = 0.55, with an increment of values since MD-4 to MD-1 (27.22 to 29.04). However, the interaction between supplementation condition and moment condition, F<1, was not significant. Regarding RJ RSI, a repeated measures ANOVA with participants’ mean RJ RSI revealed a significant main effect of supplementation condition, F (1.7) = 22.88, p = 0.001, η2 = 0.76, with higher values in the supplementation condition (1.29±0.22) than in the placebo condition (1.16±0.16). Thus, we found a main effect of moment, (2.14) = 12.91, p = 0.001, η2 = 0.64, with an increment of values thought the week (1.10 to 1.27). The interaction between supplementation condition and moment condition, F<1, was not significant. Another repeated measures ANOVA with participants’ mean RJ min jump revealed a significant main effect of of moment, (2.14) = 15.18, p = 0.001, η2 = 0.68, with an increment of values thought the week (18.89 to 23.77). Nonetheless, the main effect of supplementation condition neither the interaction between supplementation condition and moment condition, F<1, was not significant. Crucially, the repeated measures ANOVA with participants’ mean RJ max jump did not revealed any significant main effects [Supplementation, (1.7) = 1.53, p = 0.25, η2 = 0.17; Moment, F<1]. The interaction between supplementation condition and moment condition, (2.14) = 1.85, p = 0.19, η2 = 0.29, neither was significant. Another repeated measures ANOVA with participants’ mean RJ fatigue index revealed a significant main effect of supplementation condition, F (1.7) = 7.33, p = 0.03, η2 = 0.51, with higher values in the supplementation condition (102.81±12.04) than in the placebo condition (95.28±11.94). However, the main effect of moment, (2.14) = 1.20, p = 0.32, η2 = 0.14, and the interaction between supplementation condition and moment condition, F<1, were not significant. Last, a repeated measures ANOVA with participants’ mean stress did not showed a significant main effect of supplementation condition, F<1. Nevertheless, dataset revealed a significant effect of moment (1.7) = 4.69, p = 0.02, η2 = 0.40, with a decrement of values thought the week (3.81 to 2.88). The interaction between supplementation condition and moment condition, F (2.14) = 1.58, p = 0.23, η2 = 0.18, was not significant. Last, another repeated measures ANOVA with participants’ mean RJ time cont. revealed a significant main effect of moment, F (2.14) = 20.81, p = 0.001, η2= 0.74. In this sense, dataset did not reveal any main effect of supplementation condition, neither interaction between supplementation condition and moment condition, F<1, in both cases.
At this point, a correlation analysis was performed between participants’ mean of supplementation condition (supplementation and placebo) of external intensity: Handgrip dominant and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count, and participants’ mean of supplementation condition (supplementation and placebo) of internal intensity: Sleep, Stress, Fatigue and Muscle soreness. Negative large correlations were found between placebo RJ min jump and placebo stress (r=-.75 and p=.02*). In addition, other supplementation RJ time con and Placebo Sleep (r=.72 and p=.03*). No other correlations were found. (See
Table 2 and Figure 1, for more information).
Table 2.
Internal and external values.
Table 2.
Internal and external values.
|
Suplementation Condition |
Placebo condition |
|
MD-4 |
MD-3 |
MD-1 |
MD-4 |
MD-3 |
MD-1 |
Internal intensity |
Sleep (AU) |
3.38 ± 1.92 |
2.88 ± 2.10 |
2.88± 1.81 |
4.38 ±1.77 |
3.50 ± 1.51 |
2.88 ± 1.81 |
Fatigue (AU) |
3.00 ± 1.51 |
3.13 ± 1.36 |
3.25 ± 2.19 |
4.00 ± 1.60 |
3.63 ± 1.60 |
3.50 ± 1.93 |
Stress (AU) |
3.75 ± 1.28 |
3.50 ± 1.85 |
2.88 ± 1.73 |
3.88 ± 0.99 |
4.25 ± 1.39 |
2.88 ± 1.13 |
Muscle Soreness (AU) |
2.63 ± 1.19 |
3.13 ± 1.55 |
3.50 ± 2.33 |
3.25 ± 1.04 |
3.88 ± 1.46 |
4.50 ± 1.41 |
External Intensity |
Handgrip dominant (kg) |
33.61 ± 4.10 |
35.58 ± 3.71 |
35.04 ± 3.46 |
34.46 ± 3.73 |
33.19 ± 3.21 |
35.35 ± 4.71 |
Hand non-dominant(kg) |
31.83 ± 4.39 |
32.51 ± 4.16 |
31.01 ± 4.63 |
32.62 ± 2.08 |
32.23 ± 4.47 |
32.60 ± 3.89 |
COD 505 test (sec) |
4.32 ± 0.19 |
4.17 ± 0.19 |
4.13 ± 0.14 |
4.31 ± 0.23 |
4.17 ± 0.19 |
4.15 ± 0.11 |
CMJ height (cm) |
34.18 ± 5.60 |
37.18 ± 4.70 |
35.47 ± 6.09 |
30.69 ± 4.42 |
34.72 ± 5.95 |
33.88 ± 6.99 |
RJ height (cm) |
28.27 ± 2.76 |
30.28 ± 2.40 |
30.29 ± 3.41 |
26.18 ± 2.61 |
28.54 ± 4.53 |
27.79 ± 2.98 |
RJ RSI (m/s) |
1.18 ± 0.16 |
1.35 ± 0.25 |
1.35 ± 0.26 |
1.02 ± 0.16 |
1.26 ± 0.17 |
1.19 ± 0.15 |
RJ min Jump (cm) |
20.32 ± 2.36 |
24.73 ± 2.58 |
23.07 ± 2.68 |
19.45 ± 3.68 |
24.25 ± 5.30 |
24.48 ± 4.37 |
RJ max jump (cm) |
34.16 ± 2.09 |
32.77 ± 3.63 |
32.09 ± 3.79 |
31.33± 3.71 |
32.64 ± 3.75 |
32.53 ± 3.68 |
RJ fat index (%) |
108.70 ± 14.40 |
101.98 ± 12.02 |
97.75 ± 9.69 |
94.98 ± 12.85 |
96.25 ± 11.51 |
94.60 ±11.47 |
RJ contact time (s) |
0.34 ± 0.11 |
0.25 ± 0.04 |
0.23 ± 0.03 |
0.32±0.11 |
0.25 ± 0.06 |
0.25 ± 0.05 |
Table 3.
Pearson correlation coefficient between (i) internal intensity: Sleep, Stress, Fatigue and Muscle soreness, and (ii) external intensity: Handgrip dominant and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count (mean ± SD). *Significance at p < 0.05. **Significance at p < 0.01.
Table 3.
Pearson correlation coefficient between (i) internal intensity: Sleep, Stress, Fatigue and Muscle soreness, and (ii) external intensity: Handgrip dominant and non-dominant, COD 505 test, CMJ height, RJ height, RJ RSI, RJ min Jump, RJ max jump, RJ fat index, RJ time count (mean ± SD). *Significance at p < 0.05. **Significance at p < 0.01.
|
S Sleep |
P Sleep |
S Fat |
P Fat |
S Stress |
P Stress |
S MS |
P MS |
S HG Dom |
r=.12 |
r=-.01 |
r=.13 |
r=-.12 |
r=.12 |
r=-.57 |
r=.01 |
r=-.13 |
p=.76 |
p=.98 |
p=.73 |
p=.74 |
p=.75 |
p=.10 |
p=.97 |
p=.73 |
P HG Dom |
r=-.17 |
r=-.17 |
r=.11 |
r=-.05 |
r=.14 |
r=-.59 |
r=.14 |
r=.02 |
p=.65 |
p=.65 |
p=.76 |
p=.89 |
p=.70 |
p=.09 |
p=.70 |
p=.94 |
S HG Non-Dom |
r=-.38 |
r=-.29 |
r=.06 |
r=.11 |
r=.25 |
r=-.48 |
r=.32 |
r=.16 |
p=.31 |
p=.43 |
p=.87 |
p=.76 |
p=.50 |
p=.18 |
p=.38 |
p=.67 |
P HG Non-Dom |
r=-.01 |
r=-.03 |
r=.27 |
r=-.13 |
r=.12 |
r=-.57 |
r=.01 |
r=-.17 |
p=.99 |
p=.93 |
p=.47 |
p=.75 |
p=.75 |
p=.10 |
p=.97 |
p=.66 |
S COD 505 test |
r=.17 |
r=-.10 |
r=.08 |
r=.20 |
r=.11 |
r=.06 |
r=.23 |
r=.44 |
p=.65 |
p=.78 |
p=.83 |
p=.59 |
p=.76 |
p=.85 |
p=.54 |
p=.22 |
P COD 505 test |
r=.15 |
r=-.17 |
r=.09 |
r=.32 |
r=.15 |
r=.26 |
r=.29 |
r=.50 |
p=.69 |
p=.65 |
p=.79 |
p=.39 |
p=.68 |
p=.48 |
p=.44 |
p=.17 |
S CMJ height |
r=-.01 |
r=.25 |
r=.03 |
r=.01 |
r=-.04 |
r=.16 |
r=.03 |
r=-.22 |
p=.96 |
p=.51 |
p=.93 |
p=.98 |
p=.90 |
p=.67 |
p=.93 |
p=.55 |
P CMJ height |
r=-.04 |
r=.32 |
r=-.04 |
r=-.21 |
r=-.16 |
r=-.08 |
r=-.14 |
r=-.43 |
p=.89 |
p=.39 |
p=.90 |
p=.58 |
p=.67 |
p=.82 |
p=.71 |
p=.24 |
S RJ height |
r=-.09 |
r=-.26 |
r=-.14 |
r=.06 |
r=.04 |
r=.08 |
r=.02 |
r=.45 |
p=.80 |
p=.49 |
p=.70 |
p=.87 |
p=.91 |
p=.83 |
p=.95 |
p=.21 |
P RJ height |
r=-.13 |
r=-.37 |
r=-.26 |
r=-.06 |
r=.08 |
r=.40 |
r=-.05 |
r=.28 |
p=.73 |
p=.32 |
p=.49 |
p=.86 |
p=.83 |
p=.28 |
p=.88 |
p=46 |
S RJ RSI sup |
r=-.19 |
r=-.13 |
r=-.05 |
r=.01 |
r=-.09 |
r=-.34 |
r=.17 |
r=.17 |
p=.62 |
p=.73 |
p=.88 |
p=.98 |
p=.81 |
p=.36 |
p=.65 |
p=.65 |
P RJ RSI plac |
r=.06 |
r=.18 |
r=.07 |
r=.04 |
r=-.05 |
r=-.24 |
r=.24 |
r=.12 |
p=.86 |
p=.62 |
p=.84 |
p=.91 |
p=.88 |
p=.53 |
p=.52 |
p=.75 |
S RJ min jump |
r=.09 |
r=.17 |
r=.15 |
r=.11 |
r=.16 |
r=-.21 |
r=.05 |
r=.32 |
p=.79 |
p=.66 |
p=.69 |
p=.77 |
p=.67 |
p=.57 |
p=.88 |
p=.39 |
P RJ min jump |
r=-.20 |
r=.07 |
r=-.27 |
r=-.51 |
r=-.49 |
r=-.75 |
r=-.41 |
r=-.52 |
p=.59 |
p=.85 |
p=.47 |
p=.15 |
p=.17 |
p=.02* |
p=.26 |
p=.14 |
S RJ max jump |
r=.18 |
r=.44 |
r=.13 |
r=.02 |
r=-.20 |
r=-.36 |
r=.07 |
r=-.09 |
p=.63 |
p=.22 |
p=.72 |
p=.94 |
p=.60 |
p=.33 |
p=.85 |
p=.81 |
P RJ max jump |
r=.24 |
r=.38 |
r=-.10 |
r=-.29 |
r=-.33 |
r=-.22 |
r=-.22 |
r=-.30 |
p=.53 |
p=.31 |
p=.79 |
p=.43 |
p=.37 |
p=.55 |
p=.56 |
p=.42 |
S RJ Fat index |
r=-.27 |
r=-.42 |
r=-.32 |
r=-.11 |
r=-.17 |
r=.08 |
r=-.34 |
r=.07 |
p=.47 |
p=.24 |
p=.38 |
p=.76 |
p=.65 |
p=.82 |
p=.35 |
p=.84 |
P RJ Fat Index |
r=.18 |
r=.07 |
r=.26 |
r=.41 |
r=.28 |
r=.54 |
r=.13 |
r=.17 |
p=.63 |
p=.84 |
p=.49 |
p=.27 |
p=.45 |
p=.13 |
p=.73 |
p=.64 |
S RJ time |
r=.60 |
r=.72 |
r=.46 |
r=.36 |
r=.27 |
r=.40 |
r=.20 |
r=.09 |
p=.08 |
p=.03* |
p=.20 |
p=.33 |
p=.47 |
p=.28 |
p=.59 |
p=.81 |
P RJ time |
r=-.22 |
r=-.38 |
r=-.45 |
r=-.46 |
r=-.25 |
r=.15 |
r=-.53 |
r=-.37 |
p=.55 |
p=.30 |
p=.21 |
p=.20 |
p=.51 |
p=.70 |
p=.13 |
p=.31 |
Figure 3.
Significant correlations between values with significant correlation.
Figure 3.
Significant correlations between values with significant correlation.
Posteriorly, a multilinear regression analysis was performed to verify which values of internal intensity could be used to better explain the performance of external intensity variables.
Table 4.
4. Discussion
This study aimed to observe the acute effect of caffeine intake over the course of one week of training in semi-professional women's volleyball players. Regarding physical parameters, the CAF condition obtained better results in handgrip, but only in the dominant hand. In a similar study, an enhancement of handgrip was found after ingestion of a drink containing 3 mg of caffeine per kilogram of body weight in male players, so the results of handgrip improvement are similar in both men and women. Other studies also found similar results for improvements in CMJ after caffeine administration in lower dose (3 mg/kg) male volleyball players [
4] and badminton players. Otherwise, other studies reported an enhacement in CMJ with higher doses (≥ 6 mg/kg-1) in both female volleyball players [
39] and male volleyball players [
54].
Similarly, a subsequent study indicated that increased fiber recruitment by calcium release is associated with such high doses [
55], indicating an improvement in isometric, concentric and eccentric maximal voluntary contractions [
56]. However, in this study, the ability to maintain this improvement over a week of training with an intake of 5 mg/kg is also assessed. A main effect of supplementation was found in the repeated-measures ANOVA (F (1.7) = 8.41, p = 0.02, η
2 = 0.54) over the training week. Elsewhere, as mentioned above, volleyball is a sport where different jumps take place throughout the match, so it is essential to observe the effect of caffeine on repeated jumps as the assessment of CMJ alone could not reveal a real match situation. Thus, previous studies have investigated the effect of caffeine in RJ, obtaining improvements in male volleyball players in RJ 15 s [
4] and RJ 30 s [
54]. It should be noted that no studies have been found on the effect of caffeine on RJ 15 s in female volleyball players. Therefore, this is the first study that evaluates this parameter in women, even though it is of vital importance as previously explained. Besides, it has been observed that when evaluating this parameter there were improvements in the RSI and RJ min [
54]. Furthermore, it has been observed that when evaluating this parameter there were improvements in the RSI and RJ min.
This is evidence that caffeine could produce a better resistance to fatigue in terms of repeated jumps. This phenomenon could be due to several physiological mechanisms. Firstly, caffeine has been reported to produce hypoalgesia, whereby the decrease in pain inhibits the perception of overexertion and fatigue [
57]. Alternatively, there is stimulation of the CNS through inhibition of the adenosine antagonist receptor, as well as increased production of catecholamines, epinephrine and norepinephrine. Contradictorily, Karayigit et al. (2022) observed in women an increase in catecholamines after administration of 5.4 mg/kg body weight [
58], but this was not reflected in the FI in repeated sprints, nor in peak power, which was the case in the present investigation. However, the aforementioned study found an improvement in the mean power output of repeated sprints compared to placebo. Another important aspect of caffeine is the increased production of lactate, which would aid the increased production of lactic anaerobic power [
15,
57,
58,
59]. Besides, caffeine enhances sodium potassium ATPase activity and intracellular calcium mobilization, indirectly affecting acetylcholine and dopamine release [
57,
58].
Caffeine attenuates the effects of fatigue by binding to adenosine receptors, reducing the RPE. However, the action of caffeine on the release and subsequent reuptake of calcium from the sarcoplasmic reticulum appears to be the reason for the attenuation of fatigue in short-duration, high-intensity tests [
60] This could be the reason for the improvement of fatigue in the 505 test, CMJ, RSI and RJ minimum. This fact could also explain the improvement in perceived fatigue with caffeine in this study (F (1.7) = 7.29, p = 0.03, η2 = 0.51). Contradictorily, a recent meta-analysis [
15] did not find an effect on RPE and agility. Similarly, a review conducted in football players also reported no statistical change in perceived fatigue in women [
33]. A recent study reported an increased RPE with the administration of high doses of caffeine (>6mg/kg of) [
55], while Del Coso et al. (2014) reported a lower RPE score (although not significant) in male volleyball players [
4]. In addition, these authors documented a higher insomnia when caffeine was consumed, in contrast to the present study, which did not find a decrease in sleep. Filip-Stachnik (2022) assessed sleep by actigraphy after caffeine intake (3 mg/kg) prior to an evening training session and found no sleep disturbance [
39] as in this study. In this sense, the results are contradictory, as other previous studies have found a decrease in sleep. Miller et al., (2014) showed a decrease in sleep efficiency in triathletes after administration of two doses of 3 mg/kg [
61]. A subsequent study found similar results in 800 m athletes with the administration of 6 mg/kg caffeine [
37]. It has been suggested that the differences found in the studies could be due to the difference in dose, due to a stimulation of catecholamines and a decrease in 6-sulphatoxymelatonin [
39]. However, in the present study no differences were found after administration of 5 mg/kg.
Concerning muscle damage, a main effect of caffeine was found in relation to perceived muscle damage (F (1.7) = 7.29, p = 0.03, η2 = 0.51). Accordingly, it has been suggested that pre-exercise caffeine intake could improve perceived muscle damage [
40]. In this regard, a meta-analysis revealed that caffeine decreased muscle damage after 48h post-exercise compared to placebo [
62]. Thus, in this study, the participants trained on Tuesdays, Thursdays and Fridays, with the results coinciding with the aforementioned study. This could be since caffeine could improve peripheral neuromuscular transmission [
63] Caffeine would delay the failure of postsynaptic transmission [
64], as well as the decrease of membrane action potentials [
65], and inhibition of the nervous system central on motor neurons [
66].
This study has some limitations. Firstly, the number of the sample-size, although a sample calculation was previously carried out in a similar study. The power analysis conducted in the aforementioned study determined that a minimum sample size of 5 athletes was necessary [
67]. Secondly, although the players were urged not to consume caffeine on measurement days, they were regular coffee drinkers, which could affect the results of the study. However, recent research found that regular caffeine consumption did not interfere with the potential of caffeine as an ergogenic aid in explosive exercise enhancement [
68]. Similarly, a recent study reported that caffeine intake of 3-6 mg/kg improved 1RM in women habituated to caffeine ingestion [
69]. Finally, the menstrual cycle of the women was not controlled. However, several studies reported that caffeine has ergogenic effect in all phases of the menstrual cycle [
41,
70,
71].